Literature DB >> 23390207

Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.

Marcus Y Chen, Kerrie Stevens, Robin Tideman, Angelo Zaia, Takehiro Tomita, Christopher K Fairley, Monica Lahra, David Whiley, Geoff Hogg.   

Abstract

Entities:  

Keywords:  Neisseria gonorrhoeae; antibiotics; gonococcal; pharynx; resistance

Mesh：

Substances：

Year:  2013        PMID： 23390207     DOI： 10.1093/jac/dkt017

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  33 in total

1.  The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization.

Authors:  Magnus Unemo; Daniel Golparian; Leonor Sánchez-Busó; Yonatan Grad; Susanne Jacobsson; Makoto Ohnishi; Monica M Lahra; Athena Limnios; Aleksandra E Sikora; Teodora Wi; Simon R Harris
Journal:  J Antimicrob Chemother       Date:  2016-07-17       Impact factor: 5.790

2.  First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea?

Authors:  Magnus Unemo; Daniel Golparian; Bengt Hellmark
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 4.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

5.  Insights in public health: The hidden epidemic: sexually transmitted diseases in 2014.

Authors:  Alan R Katz
Journal:  Hawaii J Med Public Health       Date:  2014-08

6.  High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.

Authors:  Susanne Jacobsson; Daniel Golparian; Richard A Alm; Michael Huband; John Mueller; Jorgen Skov Jensen; Makoto Ohnishi; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

7.  Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae.

Authors:  Daniel Golparian; William M Shafer; Makoto Ohnishi; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

8.  High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.

Authors:  Magnus Unemo; Johan Ringlander; Catherine Wiggins; Hans Fredlund; Susanne Jacobsson; Michelle Cole
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

9.  Effect of Variants of Penicillin-Binding Protein 2 on Cephalosporin and Carbapenem Susceptibilities in Neisseria gonorrhoeae.

Authors:  Amrita Bharat; Walter Demczuk; Irene Martin; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

10.  Management of Gonorrhea in Adolescents and Adults in the United States.

Authors:  Sarah Kidd; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.